“Commercial interests, reporting bias, secrecy, ethically dubious studies and inertia are the ingredients of contemporary research and publication practices.”
We need to restore the credibility of the "E" of EBM starting from med publishing
[with Tom Jefferson] IThttps://t.co/0NCsrm9xq9@pash22 pic.twitter.com/vimm99gLHj— Luca De Fiore (@lucadf) February 2, 2017